Control by tra-1 of Sexual Differentiation in C. elegans
tra-1 控制线虫性别分化
基本信息
- 批准号:8291597
- 负责人:
- 金额:$ 30.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectCaenorhabditis elegansCell SeparationCellsChIP-seqCongenital AbnormalityDataDefectDevelopmentDiseaseEmbryoEtiologyEventFailureFoundationsFundingFutureGenderGene Expression ProfileGene FamilyGene TargetingGenesGenitourinary systemGenomicsGoalsGonadal DysgenesisGonadal structureGrantHealthHomologous GeneHumanHuman DevelopmentInfertilityKnowledgeLarvaLearningLinkLogicMaintenanceMalignant NeoplasmsMalignant neoplasm of testisMammalsMediatingMedicalMeiosisMessenger RNAMitosisMolecularMolecular GeneticsMusMuscleNematodaOncogene ProteinsOogenesisOrganOrganogenesisPathway interactionsPatternPhysiologyPlayPrimordiumPsychological ImpactRegulatory PathwayReporterReproductive BiologyReproductive PhysiologyResearchResourcesRoleSexual DevelopmentSomatic CellSpecificityTechnologyTissue DifferentiationTissuesTranslatingVertebratesWorkbasecell typechromatin immunoprecipitationgenome-widegonadal cancerhuman diseaseinnovationinsightmalemalformationpostnatalprecursor cellprogramsreproductivesexsex determinationsexual dimorphismsmoothened signaling pathwaysperm celltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Sexual differentiation is central to normal development and human disease but the molecular mechanisms controlling it remain poorly understood. The long-term goal of this project is to use C. elegans to understand the molecular basis of sexual dimorphism and sex-specific organogenesis. The overall strategy of the PI is to use C. elegans to define conserved factors regulating sexual dimorphism and reveal mechanisms that control sex-specific development, and then examine how homologous factors control sexual dimorphism in mice. This unique approach has yielded major advances such as the discovery of the vertebrate Dmrt1 genes, which are involved in sex determination, gonadal differentiation, DSD, and testicular cancer. The main foci of this application are how the master sex-determining gene TRA-1 imposes sex-specific development and controls oogenesis in C. elegans, and how gonad-specific regulators control early gonadogenesis. Guided by strong preliminary data, the specific aims are 1) to determine how TRA-1 controls sexual differentiation and oogenesis by identifying the genes regulated by TRA-1 and dissecting their functions in reproductive tissues; and 2) to determine how organ-specific regulators control gonad sexual dimorphism by combining isolated cell transcriptome analysis with functional studies. The proposed research will uncover the molecular basis of a critical but poorly understood aspect of development, using innovative approaches and technologies including genome-wide ChIP analysis (ChIP-seq) and cell type-specific transcriptome analysis. This work has direct relevance to human health: TRA-1 is the nematode homolog of the GLI oncoprotein, which is involved in human cancer and birth defects. Furthermore, failure of sexual differentiation or gonadal differentiation causes human sex reversal, sexual ambiguity, urogenital malformation, infertility, and gonadal cancer, which are common and serious medical conditions but usually of unknown etiology. Work funded by this grant led to the discovery of vertebrate DM domain genes, which are involved in all of these human conditions. The studies in this proposal will continue to advance the mechanistic understanding of how conserved regulators impose sex specificity on organogenesis in C. elegans and will instruct ongoing studies in mammals.
PUBLIC HEALTH RELEVANCE: Defects in sexual differentiation are among the most common causes of human birth defects and are closely linked to human cancer. The genes we study in C. elegans that control sexual differentiation have human counterparts known to be involved in birth defects and cancer and we have previously used C. elegans to discover human genes involved in sexual differentiation and cancer. The detailed mechanistic studies we can perform in C. elegans therefore provide new insights into normal human development and human disease.
描述(由申请人提供):性分化是正常发育和人类疾病的核心,但控制它的分子机制仍然知之甚少。这个项目的长期目标是使用C。elegans了解两性异形和性别特异性器官发生的分子基础。PI的总体策略是使用C。elegans定义保守的因素调节性二型性和揭示机制,控制性别特异性发展,然后检查同源因子如何控制小鼠的性二型性。这种独特的方法已经取得了重大进展,例如发现了脊椎动物Dmrt 1基因,该基因涉及性别决定,性腺分化,DSD和睾丸癌。本研究的主要焦点是性别决定主基因TRA-1是如何在C.以及性腺特异性调节因子如何控制早期性腺发生。在强有力的初步数据的指导下,具体目标是:1)通过鉴定TRA-1调控的基因并剖析其在生殖组织中的功能,确定TRA-1如何控制性分化和卵子发生; 2)通过将分离细胞转录组分析与功能研究相结合,确定器官特异性调控因子如何控制性腺性二型性。拟议的研究将揭示一个关键但知之甚少的发展方面的分子基础,使用创新的方法和技术,包括全基因组ChIP分析(ChIP-seq)和细胞类型特异性转录组分析。这项工作与人类健康直接相关:TRA-1是GLI癌蛋白的线虫同系物,与人类癌症和出生缺陷有关。此外,性分化或性腺分化的失败导致人类性别逆转、性别模糊、泌尿生殖畸形、不育和性腺癌,这些是常见和严重的医学病症,但通常病因不明。这项资助的工作导致了脊椎动物DM结构域基因的发现,这些基因与所有这些人类疾病有关。本研究将继续推进保守调节因子如何在C.并将指导正在进行的哺乳动物研究。
公共卫生相关性:性别分化缺陷是人类出生缺陷的最常见原因之一,与人类癌症密切相关。我们在C.控制性分化的秀丽线虫与人类的同类有相似之处,已知它们与出生缺陷和癌症有关,我们以前也用过C. elegans发现人类基因参与性别分化和癌症。详细的机理研究,我们可以在C。因此,秀丽线虫为人类正常发育和人类疾病提供了新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David A. Zarkower其他文献
David A. Zarkower的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David A. Zarkower', 18)}}的其他基金
相似国自然基金
犬钩虫中Caenorhabditis elegans daf同源基因的鉴定和功能研究
- 批准号:30972181
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
利用线虫(Caenorhabditis elegans)模型研究14-3-3蛋白在机体抵御逆境因子胁迫过程中的分子作用机制
- 批准号:30771234
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Genetic Analyses of Dendrite Morphogenesis in Caenorhabditis Elegans
秀丽隐杆线虫树突形态发生的遗传分析
- 批准号:
10736702 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Modeling PIEZO associated diseases in Caenorhabditis elegans: from genetics to mechanism
秀丽隐杆线虫 PIEZO 相关疾病建模:从遗传学到机制
- 批准号:
10866791 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Regulation of synapse development by small GTPase cascades in Caenorhabditis elegans
秀丽隐杆线虫中小 GTP 酶级联对突触发育的调节
- 批准号:
10735077 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.
病毒载体介导的基因激活,以促进秀丽隐杆线虫的大规模遗传分析。
- 批准号:
10818806 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Perception of Dead Conspecifics modulates neural signaling and lifespan in Caenorhabditis elegans
对死亡同种的感知调节秀丽隐杆线虫的神经信号和寿命
- 批准号:
10828478 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
An Automated High-Content Imaging Platform for Caenorhabditis elegans
秀丽隐杆线虫自动化高内涵成像平台
- 批准号:
2327954 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Continuing Grant
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.
病毒载体介导的基因激活,以促进秀丽隐杆线虫的大规模遗传分析。
- 批准号:
10572507 - 财政年份:2023
- 资助金额:
$ 30.83万 - 项目类别:
Decrypting nociceptive signaling pathways in Caenorhabditis elegans using behavioral analysis and mass spectrometry-based proteomics
使用行为分析和基于质谱的蛋白质组学解密秀丽隐杆线虫的伤害性信号通路
- 批准号:
RGPIN-2020-05228 - 财政年份:2022
- 资助金额:
$ 30.83万 - 项目类别:
Discovery Grants Program - Individual
Caenorhabditis Elegans: a Model for Genetic Interaction between the Gut Microbiota and Intestinal Epithelial Cells
秀丽隐杆线虫:肠道微生物群和肠上皮细胞之间遗传相互作用的模型
- 批准号:
10537455 - 财政年份:2022
- 资助金额:
$ 30.83万 - 项目类别:
Caenorhabditis Elegans: a Model for Genetic Interaction between the Gut Microbiota and Intestinal Epithelial Cells
秀丽隐杆线虫:肠道微生物群和肠上皮细胞之间遗传相互作用的模型
- 批准号:
10642737 - 财政年份:2022
- 资助金额:
$ 30.83万 - 项目类别: